Most recent update: Monday, March 30, 2020 - 08:53

Bariatric News - Cookies & privacy policy

You are here

Bile acids and bariatric surgery

Bile acids mediate metabolic benefits of bariatric surgery

The investigators discovered that in mice missing Tgr5, bile diversion surgery still produced beneficial metabolic effects

A team of Vanderbilt investigators has pinpointed the role of bile acids and a specific signalling pathway in the positive metabolic effects of weight-loss surgery. The findings also suggest that the intestinal microbiome participates in post-surgery improvements and guide new treatment strategies for obesity and diabetes.

"Surgical patients can experience dramatic changes in glucose regulation while they are still in the recovery room," said Dr Charles (Robb) Flynn, associate professor of Surgery. "These operations cause metabolic changes that we don't really understand."

In the paper, ‘Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery’, reported in the journal Gastroenterology, the researchers explained that bile diversion to the ileum (GB-IL) has strikingly similar metabolic and satiating effects to Roux-en-Y gastric bypass (RYGB) in rodent obesity models. The metabolic benefits of these procedures are thought to be mediated by increased bile acids, though parallel changes in body weight and other confounding variables limits this interpretation.

In previous studies, Flynn and Dr Naji Abumrad, John L Sawyers Professor of Surgical Sciences, and others found increased levels of serum bile acids, gut compounds that help digest dietary fats, after two common bariatric operations - Roux-en-Y gastric bypass and vertical sleeve gastrectomy. Roux-en-Y gastric bypass alters the path of food through the digestive tract and changes the point where bile acids enter the small intestine, from the usual upper part of the small intestine to a site near the end.

From the left, Vance Albaugh, Robb Flynn and Naji Abumrad (seated) (Credit: John Russell)

Flynn and Abumrad worked with the Vanderbilt Mouse Metabolic Phenotyping Center to develop a simpler surgical procedure in mice that mimics the Roux-en-Y re-routing of bile acids. The procedure, called bile diversion, increases bile acids in the blood and produces all of the beneficial effects of bariatric surgery: weight loss, reduced food intake and improved oral glucose tolerance, Flynn explained.

In addition to aiding fat absorption and digestion, bile acids activate signaling pathways through two types of receptors: Tgr5 and Fxr.

In studies led by research fellow, Dr Vance Albaugh, the investigators discovered that in mice missing Tgr5, bile diversion surgery still produced beneficial metabolic effects. In mice missing intestinal Fxr, however, bile diversion surgery no longer improved oral glucose tolerance.

"Our study shows specifically that elevated bile acids following bariatric surgery work through the Fxr receptor, and that it functions in the intestine," added Flynn.

The team further found that improvements in glucose handling were accompanied by increased levels of both GLP-1 (glucagon-like peptide-1) and the intestinal bacteria Akkermansia muciniphila, and that the GLP-1 receptor was required for the beneficial effects of bariatric surgery. GLP-1 is a hormone that participates in regulating blood glucose.

"Our mouse model of bariatric surgery has allowed us to isolate the metabolic effects of bile acids and show that improvements in oral glucose handling require an Fxr-GLP-1 receptor signalling pathway," Flynn said.

The change in one species of intestinal bacteria is also intriguing, he said. Akkermansia muciniphila is associated with lean phenotypes in animal models and human beings.

"Our discovery raises the idea that finding a way to introduce this bacterium into people might have weight loss and beneficial metabolic effects," said Flynn. "There's a very tight interplay between bacteria in the gut, bile acids and metabolic effects. We're just beginning to tease this apart."

Flynn and his colleagues are continuing to explore metabolic changes following bariatric surgery in their surgical mouse model. They have also begun to study patients at the Vanderbilt Weight Loss Center to explore whether the mechanisms they've discovered in mice also hold true in people.

"We want to fully understand how the surgery is generating beneficial metabolic changes so that we can improve treatments for obesity and diabetes," he concluded.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.